International Beagle Trade

A Global Market

Laboratory beagles are an internationally traded commodity. Dogs bred in the United States are shipped to Europe and Asia. Dogs bred in the UK supply continental European labs. Dogs bred in China serve the expanding Asian pharmaceutical market. This trade follows pharmaceutical industry demand, regulatory requirements, and the geography of contract research organizations.

Unlike most commercial animal trades, the laboratory beagle market is dominated by a single supplier: Marshall BioResources, which operates breeding facilities on multiple continents and ships dogs across international borders as routine business.

European Union

The EU provides the most detailed public data on laboratory dog use and trade. In the most recent reporting period (2022):

• Total dogs used in research — approximately 10,000 across all member states.
• Imports from outside the EU — 1,763 dogs, primarily from the United States and United Kingdom.
• Reuse rate — 39% of dogs in the EU were used in more than 1 procedure before being killed. This means the same dog may be subjected to sequential studies, extending its time in the laboratory.

Country-level breakdown reveals sharp concentration:

• France — 3,961 dogs. The largest user of laboratory dogs in the EU by a significant margin. Home to multiple CRO facilities and Marshall's French breeding operation.
• Germany — 2,873 dogs. The second-largest user, driven by its large pharmaceutical industry (Bayer, Boehringer Ingelheim, Merck KGaA).
• Spain — 1,511 dogs. A growing market, with several CROs establishing or expanding Spanish operations.

These 3 countries account for the majority of all laboratory dog use in the EU. Smaller but significant users include the Netherlands, Belgium, and Denmark.

United Kingdom

The UK operates outside the EU regulatory framework since Brexit but maintains its own detailed reporting:

• MBR Acres — Marshall's UK subsidiary, located in Huntingdon, Cambridgeshire. Breeds and supplies over 2,000 beagles per year to UK and, historically, European laboratories.
• Home Office statistics — the UK reports approximately 4,000-5,000 procedures on dogs annually, with beagles constituting the vast majority.
• Camp Beagle — a sustained protest campaign established outside MBR Acres in 2021. Demonstrators maintain a near-daily presence at the facility gates, documenting transport vehicles and drawing public attention to the breeding operation. The campaign has generated significant media coverage and public pressure.

Japan

Japan's pharmaceutical industry is the world's third-largest, and its regulatory requirements mandate non-rodent testing:

• 3,189 dogs — used in FY2022 according to Ministry of Health, Labour and Welfare statistics.
• Import dependency — Japan imports a significant portion of its laboratory beagles, including from Marshall's Japanese operation and from other Asian breeders.
• 40-day quarantine — Japan imposes a 40-day quarantine period on imported dogs, adding time, cost, and stress to the transport process.

The Copenhagen Route

For years, the primary logistical corridor connecting US-bred beagles to European laboratories ran through Copenhagen, Denmark. Marshall BioResources shipped thousands of beagles annually from its North Rose, New York facility through Copenhagen's cargo handling facilities and onward to customers across the EU.

• 6,000+ beagles — shipped annually via this route at its peak.
• Disruption in 2023 — a combination of activist pressure, airline policy changes, and regulatory scrutiny disrupted the Copenhagen route. Campaigns targeting cargo airlines and ground transport companies made the logistics increasingly difficult and expensive.

The disruption did not end the trade. It rerouted it. Beagles now reach European destinations through alternative corridors, though with greater logistical complexity and cost. The episode demonstrated that supply chains can be pressured — but also that demand finds a way.

Trade Dynamics

Several factors drive the international beagle trade:

• Regulatory harmonization — ICH guidelines apply across the US, EU, and Japan, creating similar demand profiles in all 3 markets.
• Breeding capacity concentration — Marshall's dominance means many countries lack domestic breeding capacity and must import.
• Cost arbitrage — breeding beagles in certain jurisdictions is cheaper due to lower labor costs, less stringent welfare requirements, or economies of scale.
• Historical data compatibility — regulatory agencies prefer data generated in animals from the same genetic background. A study started with Marshall Beagles in the US may need to be completed with Marshall Beagles in Europe, requiring international shipment.

Sources

1. 1.EU Statistical Report, 2022. Official statistics on the use of animals for scientific purposes in EU member states, including imports, reuse rates, and country-level breakdowns.
2. 2.Japan MHLW Annual Statistics, FY2022. Ministry of Health, Labour and Welfare reporting on laboratory animal use in Japan.
3. 3.UK Home Office Annual Statistics, 2022. Statistics of scientific procedures on living animals in Great Britain, including dog numbers and facility data.